Home › Funds › ACUTA CAPITAL PARTNERS, LLC › LBRX

ACUTA CAPITAL PARTNERS, LLC position in LBRX

LB PHARMACEUTICALS INC · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 28,919 shares of LBRX (LB PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$939K, representing 0.65% of its reported portfolio and ranking #23 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)28.92K sh
Reported value held$938.57K
Portfolio Weight0.65%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's LBRX position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in LBRX in Q3 2025 at 30,000 shares (US$474K). The position peaked in Q2 2026 at 28,919 shares, worth US$939K. Across 4 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 28,919 shares valued at US$939K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 30.00K $473.70K New
Q4 2025 30.00K $667.80K Hold
Q1 2026 28.92K $713.14K Reduce
Q2 2026 28.92K $938.57K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 110 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held LBRX?

ACUTA CAPITAL PARTNERS, LLC has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is ACUTA CAPITAL PARTNERS, LLC's current position in LBRX?

As of Q2 2026, ACUTA CAPITAL PARTNERS, LLC holds 28.92K shares of LBRX (LB PHARMACEUTICALS INC), valued at $938.57K, representing 0.65% of its reported portfolio and ranking #23.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling LBRX?

In the latest 13F filing (Q2 2026), ACUTA CAPITAL PARTNERS, LLC held unchanged its position in LBRX. The position peaked in Q2 2026 at 28.92K shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, among 110 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.